PhenoTarget Biosciences, Inc.
PhenoTarget Biosciences, Inc. is a biotech startup focused on the discovery and development of first-in-class therapies for unmet medical needs including oncology, fibrosis, cardiovascular diseases and infectious diseases. We are modality agnostic that our pipeline and technology platforms span small molecules to functionalized peptides and next generation cell therapies.
-
Shoutian Zhu, PhD
CEO
-
Wenshe Liu, PhD
CSO
-
James Schaeffer, PhD
CBO
SYTE.bio Inc.
SYTE.bio is an early-stage synthetic biology company focused on the discovery, development and future commercialization of precision therapeutics using its proprietary Linear DNA and Circular RNA technology platforms. SYTE.bio aims to deliver novel and effective therapeutics and vaccines enabling precise corrective and preventive treatments for patients worldwide.
-
Martin Williams
Founder & CEO